Harald Biersack

837 total citations
33 papers, 560 citations indexed

About

Harald Biersack is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Harald Biersack has authored 33 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 17 papers in Oncology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Harald Biersack's work include Cancer therapeutics and mechanisms (13 papers), Lymphoma Diagnosis and Treatment (8 papers) and Acute Myeloid Leukemia Research (5 papers). Harald Biersack is often cited by papers focused on Cancer therapeutics and mechanisms (13 papers), Lymphoma Diagnosis and Treatment (8 papers) and Acute Myeloid Leukemia Research (5 papers). Harald Biersack collaborates with scholars based in Germany, Denmark and Saudi Arabia. Harald Biersack's co-authors include Ole Westergaard, Sanne Jensen, Frank Gieseler, Anni H. Andersen, Hendrik Lehnert, Niklas Gebauer, Dirk Rades, Veronica Bernard, Irina Gromova and Fritz Boege and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Molecular and Cellular Biology.

In The Last Decade

Harald Biersack

32 papers receiving 544 citations

Peers

Harald Biersack
Marise Weil France
Toshiya Yokozawa Japan
ML Slovak United States
Christiane Mounier France
M Beran United States
Łukasz Bołkuń Poland
Mecide Gharibo United States
Jessica Boklan United States
William Larry Gluck United States
Xiu Feng Hu Australia
Marise Weil France
Harald Biersack
Citations per year, relative to Harald Biersack Harald Biersack (= 1×) peers Marise Weil

Countries citing papers authored by Harald Biersack

Since Specialization
Citations

This map shows the geographic impact of Harald Biersack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harald Biersack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harald Biersack more than expected).

Fields of papers citing papers by Harald Biersack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harald Biersack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harald Biersack. The network helps show where Harald Biersack may publish in the future.

Co-authorship network of co-authors of Harald Biersack

This figure shows the co-authorship network connecting the top 25 collaborators of Harald Biersack. A scholar is included among the top collaborators of Harald Biersack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harald Biersack. Harald Biersack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gebauer, Niklas, Axel Künstner, Hanno M. Witte, et al.. (2021). Genomic insights into the pathogenesis of Epstein–Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing. Blood Cancer Journal. 11(5). 102–102. 40 indexed citations
2.
Witte, Hanno M., Armin Riecke, Tobias Bartscht, et al.. (2018). Trofosfamide in the treatment of elderly or frail patients with diffuse large B-cell lymphoma. Journal of Cancer Research and Clinical Oncology. 145(1). 129–136. 7 indexed citations
3.
Witte, Hanno M., Harald Biersack, Dirk Rades, et al.. (2018). Indolent lymphoma with composite histology and simultaneous transformation at initial diagnosis exhibit clinical features similar to de novo diffuse large B-cell lymphoma. Oncotarget. 9(28). 19613–19622. 4 indexed citations
4.
Bartscht, Tobias, et al.. (2017). Inhibition of TGF-β Signaling in Tumor Cells by Small Molecule Src Family Kinase Inhibitors. Anti-Cancer Agents in Medicinal Chemistry. 17(10). 1351–1356. 14 indexed citations
5.
Bartscht, Tobias, Dirk Rades, Roland Kaufmann, et al.. (2016). TGF-β Signal Transduction in Pancreatic Carcinoma Cells is Sensitive to Inhibition by the Src Tyrosine Kinase Inhibitor AZM475271. Anti-Cancer Agents in Medicinal Chemistry. 17(7). 966–972. 3 indexed citations
6.
Gebauer, Niklas, Judith Gebauer, Veronica Bernard, et al.. (2014). Prevalence of targetable oncogenic mutations and genomic alterations in Epstein–Barr virus-associated diffuse large B-cell lymphoma of the elderly. Leukemia & lymphoma. 56(4). 1100–1106. 33 indexed citations
7.
Biersack, Harald & Georg Brabant. (2013). Spätfolgen onkologischer Therapie. Der Internist. 54(10). 1221–1232. 1 indexed citations
8.
9.
10.
Elmaağaclı, Ahmet, Hellmut Ottinger, Michael Koldehoff, et al.. (2005). Reduced Risk for Molecular Disease in Patients with Chronic Myeloid Leukemia after Transplantation from a KIR-Mismatched Donor. Transplantation. 79(12). 1741–1747. 31 indexed citations
11.
Biersack, Harald, Sanne Jensen, & Ole Westergaard. (2003). Rapid Purification of DNA Topoisomerase II Containing a Hexahistidine Tag by Metal Ion Affinity Chromatography. Humana Press eBooks. 94. 235–242. 2 indexed citations
12.
Ehninger, Gerhard, Rainer Schwerdtfeger, Harald Biersack, et al.. (2003). Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia. Annals of Hematology. 82(6). 336–342. 83 indexed citations
13.
Gromova, Irina, Harald Biersack, Sanne Jensen, et al.. (1998). Characterization of DNA Topoisomerase IIα/β Heterodimers in HeLa Cells. Biochemistry. 37(47). 16645–16652. 9 indexed citations
14.
Boege, Fritz, Harald Biersack, & Peter Meyer. (1994). Drug-Sensitivity and DNA-Binding of a Subform of Topoisomerase Iiα in Resistant Human HL-60 Cells. Acta Oncologica. 33(7). 799–806. 4 indexed citations
15.
Gieseler, Frank, et al.. (1994). Cytotoxicity of anthracyclines: Correlation with cellular uptake, intracellular distribution and DNA binding. Annals of Hematology. 69(1). S13–S17. 24 indexed citations
16.
17.
Boege, Fritz, Eigil Kjeldsen, Frank Gieseler, Jan Alsner, & Harald Biersack. (1993). A drug‐resistant variant of topoisomerase IIα in human HL‐60 cells exhibits alterations in catalytic pH optimum, DNA binding and sub‐nuclear distribution. European Journal of Biochemistry. 218(2). 575–584. 11 indexed citations
18.
Boege, Fritz, et al.. (1992). Activation of topoisomerase II during partial purification by heparin—Sepharose chromatography. Journal of Chromatography A. 625(1). 67–71. 5 indexed citations
19.
Gieseler, Frank, et al.. (1991). Nuclear Topoisomerase II Activity Changes During HL-60 Leukemic Cell Differentiation: Alterations in Drug Sensitivity and pH Dependency. Leukemia & lymphoma. 5(4). 273–279. 4 indexed citations
20.
Boege, Fritz, Frank Gieseler, Harald Biersack, & Michael J. Clark. (1991). Use of anion-exchange chromatography and chromatofocusing to reveal the structural and functional heterogeneity of topoisomerase II in a HL-60 cell line resistant to multi-drug treatment. Journal of Chromatography A. 587(1). 3–9. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marise Weil Breakdown of academic impact, for papers by Toshiya Yokozawa Breakdown of academic impact, for papers by ML Slovak Breakdown of academic impact, for papers by Christiane Mounier Breakdown of academic impact, for papers by M Beran Breakdown of academic impact, for papers by Łukasz Bołkuń Breakdown of academic impact, for papers by Mecide Gharibo Breakdown of academic impact, for papers by Jessica Boklan Breakdown of academic impact, for papers by William Larry Gluck Breakdown of academic impact, for papers by Xiu Feng Hu
Rankless by CCL
2026